Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Why the low margin Danish nursing home sector is attracting attention

Denmark is a relatively small market, with a population of less than six million, and like the rest of the Nordics its politics can often be very hostile to for-profit operators. Despite this, the for-profit care home sector is growing despite relatively low returns. HBI talks to two market experts about the appeal and development of the Danish nursing home sector.

Korian further consolidates French mental health

Korian, the major pan-European elder care group, continues its consolidation of the mental health sector in France. It has just entered exclusive negotiations to acquire the Osny psychotherapy centre based in the Paris region. HBI looks at this, and other recent acquisitions.

EMC plans Moscow IPO

Russia's second-largest healthcare operator by revenue, European Medical Center (EMC), has announced an intention to float in Moscow but will not be raising any proceeds from the process.

Antin considers sale of €1bn Almaviva

HBI hears that Antin Infrastructure Partners is considering the sale of Almaviva Sante, the fourth largest French hospital group by revenue. HBI speaks to a France-based consultant to find out more and to talk about potential suitors.

Looking to build an ophtha pipeline? Sell glasses first

What is the key to a regular throughput of profitable ophthalmology clients, and how does an operator fill its clinics? According to Ulla Näpänkangas, ophthalmologist and CEO of Finland-based Silmäasema Silmäsairaala, the answer lies in selling them glasses first.

Buyers move in on Lifebrain as Charme confirms Bianalisi

First-round bids have come in for Italy's largest lab group Lifebrain, with few surprises among the names. It's the second big move in the Italian lab market after Charme Capital confirmed it has bought smaller rival Bianalisi.  Multiples in the sector are hitting 16x EBITDA.

Dutch regulator halts another deal

The Dutch competition authority has paused Bergman's acquisition of dermatology specialist Mauritskliniek, saying that prices rose two years ago when it acquired NL Healthcare Clinics. Data shows that private equity is making fewer transactions in the market.

Find Us